These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19152403)

  • 1. Analysis of gene transcription in sera during chronic hepatitis C infection.
    Carpentier A; Conti F; Carrière M; Aoudjehane L; Miroux C; Moralès O; Calmus Y; Groux H; Auriault C; Pancré V; Delhem N; Podevin P
    J Med Virol; 2009 Mar; 81(3):473-80. PubMed ID: 19152403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles of genes associated with viral entry in HCV-infected human liver.
    Nakamuta M; Fujino T; Yada R; Aoyagi Y; Yasutake K; Kohjima M; Fukuizumi K; Yoshimoto T; Harada N; Yada M; Kato M; Kotoh K; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    J Med Virol; 2011 May; 83(5):921-7. PubMed ID: 21412800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
    Boya P; Larrea E; Sola I; Majano PL; Jiménez C; Civeira MP; Prieto J
    Hepatology; 2001 Nov; 34(5):1041-8. PubMed ID: 11679977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C.
    Asselah T; Bièche I; Laurendeau I; Paradis V; Vidaud D; Degott C; Martinot M; Bedossa P; Valla D; Vidaud M; Marcellin P
    Gastroenterology; 2005 Dec; 129(6):2064-75. PubMed ID: 16344072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
    Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
    Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption.
    Carrière M; Rosenberg AR; Conti F; Chouzenoux S; Terris B; Sogni P; Soubrane O; Calmus Y; Podevin P
    J Viral Hepat; 2006 Sep; 13(9):633-42. PubMed ID: 16907851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.
    Smith MW; Yue ZN; Korth MJ; Do HA; Boix L; Fausto N; Bruix J; Carithers RL; Katze MG
    Hepatology; 2003 Dec; 38(6):1458-67. PubMed ID: 14647057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection.
    Aceti A; Mangoni ML; Pasquazzi C; Fiocco D; Marangi M; Miele R; Zechini B; Borro M; Versace I; Simmaco M
    J Viral Hepat; 2006 Dec; 13(12):821-7. PubMed ID: 17109681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
    Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    Askar E; Bregadze R; Mertens J; Schweyer S; Rosenberger A; Ramadori G; Mihm S
    J Med Virol; 2009 Jul; 81(7):1204-11. PubMed ID: 19475618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
    Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
    Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum soluble Fas, Fas ligand and fas in intrahepatic lymphocytes in chronic hepatitis C.
    Zaki Mel S; Auf FA; Ghawalby NA; Saddal NM
    Immunol Invest; 2008; 37(2):163-70. PubMed ID: 18300041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
    Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant reactivation of hepatitis C virus: lymphocyte infiltration and the expression of adhesion molecules and their ligands in liver allografts.
    Lipson K; Lappalainen M; Höckerstedt K; Lautenschlager I
    APMIS; 2006 Apr; 114(4):247-54. PubMed ID: 16689823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
    Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
    Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.